share_log
Reuters ·  Dec 31, 2024 22:24
Scisparc Announces Renewal of Approval by Israeli Medical Cannabis Agency for Its Clinical Trial in Children With Autism Spectrum Disorder
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment